Search details
1.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35636444
2.
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.
J Clin Oncol
; : JCO2301648, 2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38484206
3.
Riluzole for treating spasticity in patients with chronic traumatic spinal cord injury: Study protocol in the phase ib/iib adaptive multicenter randomized controlled RILUSCI trial.
PLoS One
; 18(1): e0276892, 2023.
Article
in English
| MEDLINE | ID: mdl-36662869
4.
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer.
EBioMedicine
; 92: 104633, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37244159
5.
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer.
Clin Cancer Res
; 29(12): 2291-2298, 2023 06 13.
Article
in English
| MEDLINE | ID: mdl-37022350
6.
Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring.
Cancers (Basel)
; 14(5)2022 Feb 24.
Article
in English
| MEDLINE | ID: mdl-35267475
7.
The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival.
Cancers (Basel)
; 13(3)2021 Jan 28.
Article
in English
| MEDLINE | ID: mdl-33525361
8.
Discovery of new small molecules that influence neuroblast cell migration from the subventricular zone.
Bioorg Med Chem Lett
; 18(1): 169-74, 2008 Jan 01.
Article
in English
| MEDLINE | ID: mdl-18024032
9.
The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion.
J Neurosci
; 23(27): 9229-39, 2003 Oct 08.
Article
in English
| MEDLINE | ID: mdl-14534257
Results
1 -
9
de 9
1
Next >
>>